173 related articles for article (PubMed ID: 37110604)
1. Development of Type 1 Diabetes in Mice Is Associated with a Decrease in IL-2-Producing ILC3 and FoxP3
Saksida T; Paunović V; Koprivica I; Mićanović D; Jevtić B; Jonić N; Stojanović I; Pejnović N
Molecules; 2023 Apr; 28(8):. PubMed ID: 37110604
[TBL] [Abstract][Full Text] [Related]
2. Modulation of Intestinal ILC3 for the Treatment of Type 1 Diabetes.
Stojanović I; Saksida T; Miljković Đ; Pejnović N
Front Immunol; 2021; 12():653560. PubMed ID: 34149694
[TBL] [Abstract][Full Text] [Related]
3. KLRG1 expression identifies short-lived Foxp3
Kornete M; Mason E; Istomine R; Piccirillo CA
Autoimmunity; 2017 Sep; 50(6):354-362. PubMed ID: 28850267
[TBL] [Abstract][Full Text] [Related]
4. Transient Depletion of Foxp3
Watts D; Janßen M; Jaykar M; Palmucci F; Weigelt M; Petzold C; Hommel A; Sparwasser T; Bonifacio E; Kretschmer K
Front Immunol; 2021; 12():720133. PubMed ID: 34447385
[TBL] [Abstract][Full Text] [Related]
5. Defective differentiation of regulatory FoxP3+ T cells by small-intestinal dendritic cells in patients with type 1 diabetes.
Badami E; Sorini C; Coccia M; Usuelli V; Molteni L; Bolla AM; Scavini M; Mariani A; King C; Bosi E; Falcone M
Diabetes; 2011 Aug; 60(8):2120-4. PubMed ID: 21646390
[TBL] [Abstract][Full Text] [Related]
6. Impact of protective IL-2 allelic variants on CD4+ Foxp3+ regulatory T cell function in situ and resistance to autoimmune diabetes in NOD mice.
Sgouroudis E; Albanese A; Piccirillo CA
J Immunol; 2008 Nov; 181(9):6283-92. PubMed ID: 18941219
[TBL] [Abstract][Full Text] [Related]
7. Thymically-derived Foxp3+ regulatory T cells are the primary regulators of type 1 diabetes in the non-obese diabetic mouse model.
Holohan DR; Van Gool F; Bluestone JA
PLoS One; 2019; 14(10):e0217728. PubMed ID: 31647813
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-35 administration counteracts established murine type 1 diabetes--possible involvement of regulatory T cells.
Singh K; Kadesjö E; Lindroos J; Hjort M; Lundberg M; Espes D; Carlsson PO; Sandler S; Thorvaldson L
Sci Rep; 2015 Jul; 5():12633. PubMed ID: 26224624
[TBL] [Abstract][Full Text] [Related]
9. Modulation of Gut Microbiota by Low Methoxyl Pectin Attenuates Type 1 Diabetes in Non-obese Diabetic Mice.
Wu C; Pan LL; Niu W; Fang X; Liang W; Li J; Li H; Pan X; Chen W; Zhang H; Lakey JRT; Agerberth B; de Vos P; Sun J
Front Immunol; 2019; 10():1733. PubMed ID: 31417546
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of Foxp3 expression in mouse and human Treg is IL-2/STAT5 dependent: implications for the NOD STAT5B mutation in diabetes pathogenesis.
Murawski MR; Litherland SA; Clare-Salzler MJ; Davoodi-Semiromi A
Ann N Y Acad Sci; 2006 Oct; 1079():198-204. PubMed ID: 17130555
[TBL] [Abstract][Full Text] [Related]
11. IL-2 promotes the function of memory-like autoregulatory CD8+ T cells but suppresses their development via FoxP3+ Treg cells.
Shameli A; Yamanouchi J; Tsai S; Yang Y; Clemente-Casares X; Moore A; Serra P; Santamaria P
Eur J Immunol; 2013 Feb; 43(2):394-403. PubMed ID: 23180662
[TBL] [Abstract][Full Text] [Related]
12. Ethyl Pyruvate Stimulates Regulatory T Cells and Ameliorates Type 1 Diabetes Development in Mice.
Koprivica I; Vujičić M; Gajić D; Saksida T; Stojanović I
Front Immunol; 2018; 9():3130. PubMed ID: 30687329
[TBL] [Abstract][Full Text] [Related]
13. ICOS-dependent homeostasis and function of Foxp3+ regulatory T cells in islets of nonobese diabetic mice.
Kornete M; Sgouroudis E; Piccirillo CA
J Immunol; 2012 Feb; 188(3):1064-74. PubMed ID: 22227569
[TBL] [Abstract][Full Text] [Related]
14. Reduced PD-1 expression on circulating follicular and conventional FOXP3
Vecchione A; Di Fonte R; Gerosa J; Jofra T; Cicalese MP; Napoleone V; Ippolito E; Galvani G; Ragogna F; Stabilini A; Bianconi E; Grogan P; Bonura C; Bonfanti R; Frontino G; Nano R; Melzi R; De Pellegrin M; Laurenzi A; Meschi F; Barera G; Rigamonti A; Indirli R; Bosi E; Piemonti L; Aiuti A; Battaglia M; Fousteri G
Clin Immunol; 2020 Feb; 211():108319. PubMed ID: 31794865
[TBL] [Abstract][Full Text] [Related]
15. Gut microbial markers are associated with diabetes onset, regulatory imbalance, and IFN-γ level in NOD mice.
Krych Ł; Nielsen DS; Hansen AK; Hansen CH
Gut Microbes; 2015; 6(2):101-9. PubMed ID: 25648687
[TBL] [Abstract][Full Text] [Related]
16. LAG3
Bauché D; Joyce-Shaikh B; Jain R; Grein J; Ku KS; Blumenschein WM; Ganal-Vonarburg SC; Wilson DC; McClanahan TK; Malefyt RW; Macpherson AJ; Annamalai L; Yearley JH; Cua DJ
Immunity; 2018 Aug; 49(2):342-352.e5. PubMed ID: 30097293
[TBL] [Abstract][Full Text] [Related]
17. Th1-Like ICOS+ Foxp3+ Treg Cells Preferentially Express CXCR3 and Home to β-Islets during Pre-Diabetes in BDC2.5 NOD Mice.
Kornete M; Mason ES; Girouard J; Lafferty EI; Qureshi S; Piccirillo CA
PLoS One; 2015; 10(5):e0126311. PubMed ID: 25946021
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-33 prevents the development of autoimmune diabetes in NOD mice.
Lu J; Liang Y; Zhao J; Meng H; Zhang X
Int Immunopharmacol; 2019 May; 70():9-15. PubMed ID: 30780005
[TBL] [Abstract][Full Text] [Related]
19. Surge in regulatory T cells does not prevent onset of hyperglycemia in NOD mice: immune profiles do not correlate with disease severity.
Kaminitz A; Mizrahi K; Askenasy N
Autoimmunity; 2014 Mar; 47(2):105-12. PubMed ID: 24328490
[TBL] [Abstract][Full Text] [Related]
20. Type 1 diabetes vaccine candidates promote human Foxp3(+)Treg induction in humanized mice.
Serr I; Fürst RW; Achenbach P; Scherm MG; Gökmen F; Haupt F; Sedlmeier EM; Knopff A; Shultz L; Willis RA; Ziegler AG; Daniel C
Nat Commun; 2016 Mar; 7():10991. PubMed ID: 26975663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
